Clinical trial Recruiting at 1 site Observational Ages 18 and up

Does the amount of water in brain tissue on a CT scan help predict outcomes after IV thrombolysis for acute ischemic stroke?

Official title: Quantitative Net Water Uptake as a Predictor of Functional Outcomes After Intravenous Thrombolysis in Acute Ischemic Stroke International Multicenter Observational Retrospective Study

Run by Sigmund Freud PrivatUniversitat · NCT07299981 · Data updated 2026-11-12

This study tests whether measuring quantitative net water uptake on the first CT scan can predict how well patients do after receiving intravenous thrombolysis for acute ischemic stroke.

More Ischemic Stroke trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorSigmund Freud PrivatUniversitat
Academic / other
Locations1 site (Vienna)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedApril 1, 2027
Study endsJuly 1, 2027
Registry record updatedJuly 16, 2026
Trial IDNCT07299981 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with acute ischemic stroke who were treated with intravenous thrombolysis and have suitable baseline and follow-up imaging (CT or MRI) with ASPECTS data available.

Probably not a fit

Patients with missing imaging, poor imaging quality, large preexisting infarcts, or those who did not meet inclusion criteria may not benefit from NWU-based predictions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational study analyzes acute ischemic stroke patients treated with IV thrombolysis to see if net water uptake on initial non-contrast CT predicts functional outcomes. Researchers will compare NWU values with subsequent imaging 12–24 hours after treatment and relate them to final infarct size and clinical outcomes. The study uses existing imaging data, with no experimental interventions, to explore NWU as a potential tissue clock biomarker. It aims to clarify whether NWU modifies the treatment effect of IV thrombolysis. Results could help refine prognostication and decision-making in this patient group.

Why it matters

Potential benefit: If NWU proves predictive, clinicians may better estimate outcomes after IV thrombolysis and tailor early care and counseling.

How similar studies have gone: Previous work suggests NWU relates to tissue injury and outcomes, but this study will test its role specifically as a treatment-modifying biomarker for IVT.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Acute ischemic stroke treated with intravenous thrombolysis
* Imaging with non-contrast cranial CT on admission
* Follow-up imaging with non-contrast cranial CT or MRI 12-24 hours after IVT
* Final Infarct volume \> 5ml
* ASPECTS available

Exclusion Criteria:

* Known use of oral anticoagulation (OAC) on admission
* Preexisting ischemic infarction on admission non-contrast cranial CT
* Patients with large vessel occlusion AIS who underwent mechanical thrombectomy
* Low imaging quality precluding radiological measurements
* Severe white matter lesions precluding radiological measurements
* No ASPECTS

Where it's running

  • Department of Neurology, St. John's Hospital, Vienna, Austria, Vienna, 1020
    Vienna, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

    This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

    Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

  • Remote ischemic conditioning for post-stroke insomnia

    A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.

    Recruiting Sichuan Academy of Medical Sciences · Chengdu, Sichuan · NCT07874594

  • Ear-based nerve stimulation to help sleep after a stroke

    A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.

    Recruiting Casa Colina Hospital and Centers for Healthcare · Pomona, California · NCT07858656

  • Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)

    This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.

    Recruiting Ankara Etlik City Hospital · Ankara, Yenimahalle · NCT07834333

  • Preventing another ischemic stroke with a smart bracelet and app

    This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.

    Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07825311

  • Photon-counting CT to check intracranial stents

    This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.

    Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07769814

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.